FGFR2::v
About
Gene context: FGFR2
Biomarker Type: Rearrangement
Present: True
Rearrangement Type: Fusion
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) FDA (1) | FGFR2::v | Intrahepatic Cholangiocarcinoma | Futibatinib | |
| FDA (1) | FGFR2::v | Cholangiocarcinoma | Infigratinib | |
| FDA (1) | FGFR2::v | Cholangiocarcinoma | Pemigatinib | |
| EMA (1) HSE (1) | FGFR2::v | Intrahepatic Cholangiocarcinoma | Elacestrant |